ESC Heart Failure

Scope & Guideline

Advancing heart health through groundbreaking research.

Introduction

Welcome to your portal for understanding ESC Heart Failure, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2055-5822
PublisherWILEY PERIODICALS, INC
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2014 to 2024
AbbreviationESC HEART FAIL / ESC Heart Fail.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104

Aims and Scopes

The journal 'ESC Heart Failure' is dedicated to advancing the understanding and treatment of heart failure through rigorous research and clinical studies. It serves as a platform for sharing innovative findings that address various aspects of heart failure management, epidemiology, treatment strategies, and patient outcomes.
  1. Heart Failure Management and Treatment Strategies:
    The journal focuses on the latest advancements in heart failure therapies, including pharmacological interventions, device therapies, and surgical approaches.
  2. Epidemiology and Risk Factors:
    Research on the epidemiology of heart failure, including prevalence, risk factors, and the impact of comorbidities on heart failure outcomes, is a key focus area.
  3. Diagnostic Innovations:
    The journal publishes studies on novel diagnostic techniques and biomarkers that enhance the detection and monitoring of heart failure.
  4. Patient Outcomes and Quality of Life:
    There is a strong emphasis on research that evaluates patient-reported outcomes, quality of life, and the psychosocial aspects of living with heart failure.
  5. Multi-disciplinary Approaches:
    The journal encourages research that explores multi-disciplinary care models and collaborative strategies in heart failure management.
  6. Advanced Heart Failure and Transplantation:
    Articles addressing advanced heart failure, including the use of mechanical circulatory support and heart transplantation, are prominently featured.
The journal 'ESC Heart Failure' has been evolving to address new challenges and advancements in the field. Recent publications indicate a clear trend towards integrating innovative technologies, multidisciplinary approaches, and patient-centered care in heart failure research.
  1. Digital Health and Remote Monitoring:
    There is a significant increase in research related to digital health solutions, including telemedicine and remote patient monitoring technologies for managing heart failure.
  2. Artificial Intelligence and Machine Learning:
    The utilization of AI and machine learning in predicting heart failure outcomes and personalizing treatment strategies has emerged as a prominent theme.
  3. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research focusing on HFpEF has gained traction, exploring its unique pathophysiology, management strategies, and prognostic indicators.
  4. SGLT2 Inhibitors and Novel Pharmacotherapies:
    The growing interest in SGLT2 inhibitors and other novel pharmacotherapies is evident, as studies highlight their benefits in heart failure management.
  5. Psychosocial Factors and Patient-Centered Care:
    Increased attention is being paid to psychosocial factors affecting heart failure patients, including mental health, quality of life, and health literacy.
  6. Biomarkers and Precision Medicine:
    Emerging research on biomarkers for heart failure diagnosis, prognosis, and treatment response is trending, supporting the movement towards precision medicine.

Declining or Waning

While 'ESC Heart Failure' has consistently focused on various aspects of heart failure, certain themes have shown a decline in frequency or prominence over recent years. This shift may reflect changing priorities in research funding, clinical practice, or emerging areas of interest.
  1. Traditional Risk Factor Studies:
    There has been a noticeable decrease in studies focusing on traditional cardiovascular risk factors (e.g., hypertension, hyperlipidemia) as standalone topics, with more emphasis now on complex interrelations with heart failure.
  2. Single-Center Studies:
    The prevalence of single-center studies has decreased as multi-center and large-scale studies are prioritized for their broader applicability and generalizability.
  3. Basic Science and Mechanistic Studies:
    Research focusing solely on basic science or mechanistic studies without direct clinical implications has waned, as the journal shifts towards clinically relevant applications.
  4. Historical Data Analysis:
    There is a reduced focus on retrospective analyses of historical data, as the field moves toward real-time data and prospective studies that incorporate current treatment paradigms.

Similar Journals

TEXAS HEART INSTITUTE JOURNAL

Exploring Innovations in Heart Care and Research.
Publisher: TEXAS HEART INSTISSN: 0730-2347Frequency: 6 issues/year

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Exploring the Frontiers of Cardiovascular Medicine
Publisher: ELSEVIER SCIENCE INCISSN: 0735-1097Frequency: 50 issues/year

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, the esteemed publication of Elsevier Science Inc, stands as a premier platform for advancing knowledge in the field of cardiology and cardiovascular medicine. With an impressive impact factor reflecting its prominence—ranked Q1 in its category for 2023 and occupying the 4th position out of 387 in the Scopus listings, firmly placing it in the 99th percentile—this journal is essential for researchers, clinicians, and students alike. Since its inception in 1983, it has continuously provided a vital space for high-quality research and innovative clinical practices, driving forward our understanding of cardiovascular health. While access options are not open, the value of the cutting-edge articles published here cannot be overstated, as they foster collaboration and inform better patient care across the globe. As part of its ongoing commitment to excellence, the journal solicits submissions of original research, reviews, and clinical studies that contribute meaningfully to the field and engage its diverse readership.

Current Heart Failure Reports

Advancing the Frontiers of Heart Failure Research
Publisher: SPRINGERNATUREISSN: 1546-9530Frequency: 6 issues/year

Current Heart Failure Reports, published by SpringerNature, is a leading journal dedicated to advancing the field of cardiology, specifically focusing on heart failure. With an impressive impact factor and a recognized reputation, this journal falls under the top quartiles in several categories, including Q1 in Cardiology and Cardiovascular Medicine and Emergency Medicine. Its range of topics encompasses both clinical and research insights into heart failure management, offering valuable perspectives aligned with the latest therapeutic advancements. Although it does not have open access options, researchers and practitioners can find profound studies and reviews aimed at improving patient care and outcomes in cardiovascular health. As the journal converges towards its 20th year in print, it continues to serve as a critical resource for academic professionals, providing a platform for high-quality research that shapes the future of heart failure treatments.

CURRENT CARDIOLOGY REVIEWS

Bridging Research and Practice in Cardiology
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-403XFrequency: 4 issues/year

CURRENT CARDIOLOGY REVIEWS, an esteemed journal published by BENTHAM SCIENCE PUBL LTD, is a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1573-403X and E-ISSN of 1875-6557, this journal presents comprehensive reviews that contribute significantly to the advancement of scientific knowledge and clinical practices in cardiology. Operating with open access options, CURRENT CARDIOLOGY REVIEWS is dedicated to bridging the gap between research and practice, thereby encouraging interdisciplinary collaboration and knowledge sharing. The journal has been instrumental in disseminating high-impact findings, consistently maintaining a Q2 category ranking in both Cardiology and Cardiovascular Medicine, as well as within the miscellaneous categories of Medicine, highlighting its relevance and respect in the academic community. Researchers, practitioners, and students alike will find valuable insights into contemporary cardiovascular issues, practices, and innovations that promote better patient outcomes. Based in the United Arab Emirates, CURRENT CARDIOLOGY REVIEWS encourages global contributions and reflects the latest advancements up to the year 2024, solidifying its role as an essential publication for those engaged in the quest for excellence in cardiovascular health.

Cardiology and Therapy

Exploring breakthroughs in heart health and therapy.
Publisher: SPRINGER LONDON LTDISSN: 2193-8261Frequency: 1 issue/year

Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.

CURRENT PROBLEMS IN CARDIOLOGY

Exploring the Frontiers of Cardiac Research
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Anatolian Journal of Cardiology

Empowering Cardiovascular Insights, One Article at a Time.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Korean Circulation Journal

Fostering Evidence-Based Practices in Cardiovascular Care.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Journal of the Saudi Heart Association

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

REVISTA ESPANOLA DE CARDIOLOGIA

Fostering Excellence in Cardiovascular Research
Publisher: EDICIONES DOYMA S AISSN: Frequency: 12 issues/year

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.